New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
Cat.No. | Product Name | Activity |
5081 | J 147 | Neurotrophic compound. Reduces Aβ40 and Aβ42 levels |
5062 | Cyclotraxin B | TrkB receptor antagonist |
5056 | Ki 16425 | LPA1 and LPA3 receptor antagonist |
5055 | Qc 1 | Threonine dehydrogenase inhibitor |
4982 | ML 337 | Selective negative allosteric modulator of mGlu3 |
4880 | ML 281 | STK33 inhibitor |
4874 | SR 1078 | RORα/γ agonist |
4715 | JZL 195 | Dual FAAH and MAGL inhibitor |
4679 | CYM 50358 hydrochloride | Potent and selective S1P4 antagonist |
4407 | TC-G 1004 | Potent and selective A2A antagonist |
4996 | PMX 464 | Putative inhibitor of the Trx-TrxR system; antiproliferative |
4975 | CRT 0066101 | Potent protein kinase D (PKD) inhibitor |
4954 | UAMC 00039 dihydrochloride | Dipeptidyl peptidase II (DPP-II) inhibitor |
4851 | Stoppin 2 | Competitive p53-MDM2/MDMX interaction inhibitor |